MESO:NASDAQ
Mesoblast Ltd
13,27 $
arrow_upward
+1,30%(+0,17) 1D
13 նոյ, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MESO...
Open
13,13 $
High
13,28 $
Low
12,88 $
Mkt. cap
1,75 մլրդ
Avg. vol.
276,86 հզր
Volume
347,02 հզր
52-wk high
21,50 $
52-wk low
11,89 $
EPS
-0,44 $
Beta
2,21
Shares outstanding
130,13 մլն
No. of employees
108
Open
13,13 $
High
13,28 $
Low
12,88 $
Mkt. cap
1,75 մլրդ
Avg. vol.
276,86 հզր
Volume
347,02 հզր
52-wk high
21,50 $
52-wk low
11,89 $
EPS
-0,44 $
Beta
2,21
Shares outstanding
130,13 մլն
No. of employees
108
News stories
From web sources and news partners
BigGo Finance
·
1 ժամ առաջ
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
TradingKey
·
12 ժամ առաջ
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
The Motley Fool
·
22 ժամ առաջ
Prediction: This Small-Cap Value ETF Will Beat the S&P 500 Over the Next 10 Years
StoneX
·
2 օր առաջ
S&P 500, Nasdaq 100 Claw Back But NVDA Cloud Looms Overhead
Profile
Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004. Wikipedia
About Mesoblast Ltd